Prytime Medical, Inc., a San Antonio, TX-based provider of life saving REBOA products for truncal hemorrhage control. closed a $6m inside financing.
The company intends to use the funds for the commercialization of its innovative new products.
Led by David Spencer, CEO, Prytime Medical Devices is an innovative medical device company that designs, develops, and commercializes minimally invasive solutions for hemorrhage control. The ER-REBOA PLUS, and the innovative pREBOA-PRO™ partial REBOA Catheter, enable truncal hemorrhage control and simultaneously controlled resuscitation in a wide range of clinical scenarios. pREBOA-PRO™ is the first FDA-cleared REBOA catheter designed specifically for true partial REBOA.
The company’s products have had 7500 clinical uses worldwide so far.
FinSMEs
02/06/2021